BIO vs GAP · rev $2.58B vs P/E 9.9, rev $15.09B
BIO (BIO) versus The Gap, Inc. (GAP) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
BIO currently screens at market cap $0. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Not investment advice. Open the BIO and GAP stock pages for the full models.
Not investment advice.